Bengaluru is witnessing a new wave of healthcare innovation, and Plazza, a quick medicine delivery startup, is leading the charge. Founded by former Zomato executive Aman Priyadarshi and
Bengaluru is witnessing a new wave of healthcare innovation, and Plazza, a quick medicine delivery startup, is leading the charge. Founded by former Zomato executive Aman Priyadarshi and Aniruddha Sen, co-founder of the now-defunct Kenko Health, Plazza has raised $1.4 million in a seed funding round led by All In Capital.
Other participants in the round included Better Capital, Tracxn founder Abhishek Goyal, Bounce co-founder Vivekananda Hallekere, the Singhania family office, and the promoters of JK Tyre. The fresh funding is set to accelerate Plazza’s mission to redefine pharmacy operations and medicine delivery in India.
Plazza aims to challenge the conventional pharmacy model. Most traditional pharmacies carry 4,000–5,000 SKUs, limiting their ability to provide a comprehensive range of products. Plazza, in contrast, offers 20,000 SKUs, covering everything from prescription medicines and OTC drugs to wellness supplements and healthcare essentials.
This extensive catalogue is available for customers both in-store and via delivery, making it easier for people to access medicines quickly without the limitations of stock or geographical constraints.
In a country where timely access to medicines can be critical, Plazza’s quick delivery promise is its biggest differentiator. Leveraging technology-enabled logistics, the startup ensures that customers can order medicines and receive them in record time, often within a few hours.
Aman Priyadarshi, Co-founder of Plazza, explained:
“Our goal is to make medicine delivery as fast, reliable, and convenient as ordering food online. We are building an ecosystem where customers can trust Plazza for all their healthcare needs.”
With health emergencies and daily prescriptions alike, Plazza is targeting both individual consumers and corporate wellness programs.
Plazza’s platform isn’t just a marketplace—it’s a data-driven healthcare engine. Using AI and predictive analytics, the startup can:
This technology-first approach gives Plazza a significant advantage over traditional pharmacies, which rely on manual stocking and customer walk-ins.
India’s online pharmacy and quick delivery sector is booming. The market is projected to grow at a CAGR of 25–30% over the next five years, driven by rising digital adoption, telemedicine, and increased health awareness.
Plazza is entering at the right time, providing a high SKU, quick delivery model that caters to urban populations in metros like Bengaluru, Hyderabad, Pune, and Delhi, where time-sensitive healthcare solutions are in high demand.
The $1.4 million seed funding will be deployed to:
This funding marks Plazza’s first institutional backing, signaling strong investor confidence in the startup’s potential to transform medicine delivery in India.
Both founders bring relevant experience to the table. Priyadarshi, with his Zomato background, brings expertise in scaling consumer delivery platforms, while Sen contributes deep insights from the health-tech space. Their combined experience positions Plazza to bridge the gap between digital convenience and healthcare reliability.
Priyadarshi further noted:
“We are focused on building trust and convenience. Customers should feel that Plazza is their go-to partner for all health and wellness needs.”
While the online pharmacy sector has players like 1mg, PharmEasy, and Netmeds, Plazza differentiates itself with:
This combination allows Plazza to capture both retail and long-term customer loyalty, which many online-only competitors struggle with.
Plazza’s vision is clear: reinvent pharmacy operations in India, making it easier, faster, and more reliable for consumers to access medicines. With seed funding secured and a technology-driven model, the startup plans to expand into new cities and scale both its delivery and in-store operations over the next 12–18 months.
If successful, Plazza could become a major disruptor in India’s $30 billion pharmacy market, transforming how people think about healthcare access and delivery.
